Long-Term Arthralgia after Mayaro Virus Infection Correlates with Sustained Pro-inflammatory Cytokine Response

PLoS Neglected Tropical Diseases

Volumn 9, Issue 10, 2015, Pages

  Santiago, Felix W ^a,b   Halsey, Eric S ^c   Siles, Crystyan ^c   Vilcarromero, Stalin ^c   Guevara, Carolina ^c   Silvas, Jesus A ^a,b   Ramal, Cesar ^d   Ampuero, Julia S ^c   Aguilar, Patricia V ^a,b,e  

^a Institute for Human Infections and Immunity   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c Peru   (Peru)

^d Hospital Regional   (Peru)

^e Center for Biodefense and Emerging Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; VIRUS ANTIBODY;

ARTHRALGIA; ARTICLE; BLOOD ANALYSIS; CHIKUNGUNYA VIRUS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MAYARO VIRUS; PLAQUE ASSAY; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS INFECTION; VIRUS NEUTRALIZATION; ADOLESCENT; ADULT; AGED; ALPHAVIRUS; ALPHAVIRUS INFECTION; BLOOD; COMPLICATION; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PERU; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHAVIRUS; ALPHAVIRUS INFECTIONS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ARTHRALGIA; CHILD; CYTOKINES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERU; YOUNG ADULT;

EID: 84959148543     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004104     Document Type: Article

References (54)

1. Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, Gianella A, et al. Arboviral etiologies of acute febrile illnesses in Western South America, 2000–2007. PLoS Negl Trop Dis. 2010;4(8):e787. doi: 10.1371/journal.pntd.000078720706628
2. Sanders EJ, Rwaguma EB, Kawamata J, Kiwanuka N, Lutwama JJ, Ssengooba FP, et al. O'nyong-nyong fever in south-central Uganda, 1996–1997: description of the epidemic and results of a household-based seroprevalence survey. J Infect Dis. 1999;180(5):1436–43. 10515801
3. Weaver SC, Barrett AD, Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol. 2004;2(10):789–801. 15378043
4. Hoch AL, Peterson NE, LeDuc JW, Pinheiro FP, An outbreak of Mayaro virus disease in Belterra, Brazil. III. Entomological and ecological studies. Am J Trop Med Hyg. 1981;30(3):689–98. 6266265
5. Toivanen A, Alphaviruses: an emerging cause of arthritis?Curr Opin Rheumatol. 2008;20(4):486–90. doi: 10.1097/BOR.0b013e328303220b18525365
6. Zacks MA, Paessler S, Encephalitic alphaviruses. Vet Microbiol. 2010;140(3–4):281–6. doi: 10.1016/j.vetmic.2009.08.02319775836
7. Tesh RB, Arthritides caused by mosquito-borne viruses. Annu Rev Med. 1982;33:31–40. 6123291
8. Karabatsos N, Antigenic relationships of group A arboviruses by plaque reduction neutralization testing. Am J Trop Med Hyg. 1975;24(3):527–32. 1174020
9. Phillips DA, Murray JR, Aaskov JG, Wiemers MA, Clinical and subclinical Barmah Forest virus infection in Queensland. Med J Aust. 1990;152(9):463–6. 2166224
10. Anderson CR, Downs WG, Wattley GH, Ahin NW, Reese AA, Mayaro virus: a new human disease agent. II. Isolation from blood of patients in Trinidad, B.W.I. Am J Trop Med Hyg. 1957;6(6):1012–6. 13487973
11. Aitken TH, Downs WG, Anderson CR, Spence L, Casals J, Mayaro virus isolated from a Trinidadian mosquito, Mansonia venezuelensis. Science. 1960;131(3405):986.
12. Talarmin A, Chandler LJ, Kazanji M, de Thoisy B, Debon P, Lelarge J, et al. Mayaro virus fever in French Guiana: isolation, identification, and seroprevalence. Am J Trop Med Hyg. 1998;59(3):452–6. 9749643
13. Torres JR, Russell KL, Vasquez C, Barrera R, Tesh RB, Salas R, et al. Family cluster of Mayaro fever, Venezuela. Emerg Infect Dis. 2004;10(7):1304–6. 15324555
14. Tesh RB, Watts DM, Russell KL, Damodaran C, Calampa C, Cabezas C, et al. Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis. 1999;28(1):67–73. 10028074
15. LeDuc JW, Pinheiro FP, Travassos da Rosa AP, An outbreak of Mayaro virus disease in Belterra, Brazil. II. Epidemiology. Am J Trop Med Hyg. 1981;30(3):682–8. 6266264
16. Long KC, Ziegler SA, Thangamani S, Hausser NL, Kochel TJ, Higgs S, et al. Experimental transmission of Mayaro virus by Aedes aegypti. Am J Trop Med Hyg. 2011;85(4):750–7. doi: 10.4269/ajtmh.2011.11-035921976583
17. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S, A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3(12):e201. 18069894
18. Halsey ES, Siles C, Guevara C, Vilcarromero S, Jhonston EJ, Ramal C, et al. Mayaro virus infection, Amazon Basin region, Peru, 2010–2013. Emerg Infect Dis. 2013;19(11):1839–42. doi: 10.3201/eid1911.13077724210165
19. Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis. 2008;197(11):1585–93. doi: 10.1086/58784118433328
20. Chow A, Her Z, Ong EK, Chen JM, Dimatatac F, Kwek DJ, et al. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis. 2011;203(2):149–57. doi: 10.1093/infdis/jiq04221288813
21. Ng LF, Chow A, Sun YJ, Kwek DJ, Lim PL, Dimatatac F, et al. IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One. 2009;4(1):e4261. doi: 10.1371/journal.pone.000426119156204
22. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, et al. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis. 2011;5(8):e1279. doi: 10.1371/journal.pntd.000127921858242
23. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184(10):5914–27. doi: 10.4049/jimmunol.090025520404278
24. Watts DM, Lavera V, Callahan J, Rossi C, Oberste MS, Roehrig JT, et al. Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg. 1997;56(6):661–7. Epub 1997/06/01. 9230800
25. Turell MJ, O'Guinn ML, Jones JW, Sardelis MR, Dohm DJ, Watts DM, et al. Isolation of viruses from mosquitoes (Diptera: Culicidae) collected in the Amazon Basin region of Peru. J Med Entomol. 2005;42(5):891–8. 16366001
26. Juarez D, Long KC, Aguilar P, Kochel TJ, Halsey ES, Assessment of plaque assay methods for alphaviruses. J Virol Methods. 2013;187(1):185–9. doi: 10.1016/j.jviromet.2012.09.02623085307
27. Casals J, Relationships among arthropod-borne animal viruses determined by cross-challenge tests. Am J Trop Med Hyg. 1963;12:587–96. 14044772
28. Hearn HJ, Rainey CT, Cross-protection in animals infected with group A arboviruses. J Immunol. 1963;90:720–4. 14053290
29. Cole FE, McKinney RW, Cross-protection in hamsters immunized with group A arbovirus vaccines. Infect Immun. 1971;4(1):37–43. 5154876
30. Brown A, Officer JE, An attenuated variant of Eastern encephalitis virus: biological properties and protection induced in mice. Arch Virol. 1975;47(2):123–38. 1119939
31. Morrison AC, Forshey BM, Notyce D, Astete H, Lopez V, Rocha C, et al. Venezuelan equine encephalitis virus in iquitos, peru: urban transmission of a sylvatic strain. PLoS Negl Trop Dis. 2008;2(12):e349. Epub 2008/12/17. doi: 10.1371/journal.pntd.000034919079600
32. Aguilar PV, Robich RM, Turell MJ, O'Guinn ML, Klein TA, Huaman A, et al. Endemic eastern equine encephalitis in the Amazon region of Peru. Am J Trop Med Hyg. 2007;76(2):293–8. 17297038
33. Mourão MP, Bastos MeS, de Figueiredo RP, Gimaque JB, Galusso EoS, Kramer VM, et al. Mayaro fever in the city of Manaus, Brazil, 2007–2008. Vector Borne Zoonotic Dis. 2012;12(1):42–6. doi: 10.1089/vbz.2011.066921923266
34. Aguilar PV, Adams AP, Suárez V, Beingolea L, Vargas J, Manock S, et al. Genetic characterization of Venezuelan equine encephalitis virus from Bolivia, Ecuador and Peru: identification of a new subtype ID lineage. PLoS Negl Trop Dis. 2009;3(9):e514. doi: 10.1371/journal.pntd.000051419753102
35. Griffin D, Levine B, Tyor W, Ubol S, Desprès P, The role of antibody in recovery from alphavirus encephalitis. Immunol Rev. 1997;159:155–61. 9416509
36. Kam YW, Simarmata D, Chow A, Her Z, Teng TS, Ong EK, et al. Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection. J Infect Dis. 2012;205(7):1147–54. doi: 10.1093/infdis/jis03322389226
37. Chopra A, Anuradha V, Ghorpade R, Saluja M, Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect. 2012;140(5):842–50. doi: 10.1017/S095026881100130021767452
38. Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M, Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 2008;58(9):2921–2. doi: 10.1002/art.2375318759351
39. Bouquillard E, Combe B, Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis. 2009;68(9):1505–6. doi: 10.1136/ard.2008.09762619674985
40. Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT, Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol. 2006;80(2):737–49. 16378976
41. Teng TS, Kam YW, Lee B, Hapuarachchi HC, Wimal A, Ng LC, et al. A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection. J Infect Dis. 2015;211(12):1925–35. doi: 10.1093/infdis/jiv04925635123
42. Lohachanakul J, Phuklia W, Thannagith M, Thonsakulprasert T, Ubol S, High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009–2010 outbreak in Thailand. Microbiol Immunol. 2012;56(2):134–8. doi: 10.1111/j.1348-0421.2011.00417.x22188545
43. Wynn TA, IL-13 effector functions. Annu Rev Immunol. 2003;21:425–56. 12615888
44. Yoo SA, Kwok SK, Kim WU, Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators Inflamm. 2008;2008:129873. doi: 10.1155/2008/12987319223981
45. Churchman SM, Ponchel F, Interleukin-7 in rheumatoid arthritis. Rheumatology (Oxford). 2008;47(6):753–9.
46. Lubberts E, The role of IL-17 and family members in the pathogenesis of arthritis. Curr Opin Investig Drugs. 2003;4(5):572–7. 12833651
47. Metawi SA, Abbas D, Kamal MM, Ibrahim MK, Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol. 2011;30(9):1201–7. doi: 10.1007/s10067-011-1737-y21874405
48. Chen W, Foo SS, Rulli NE, Taylor A, Sheng KC, Herrero LJ, et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. Proc Natl Acad Sci U S A. 2014;111(16):6040–5. doi: 10.1073/pnas.131885911124733914
49. Montaseri A, Busch F, Mobasheri A, Buhrmann C, Aldinger C, Rad JS, et al. IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway. PLoS One. 2011;6(12):e28663. doi: 10.1371/journal.pone.002866322194879
50. Abramson SB, Amin A, Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford). 2002;41(9):972–80.
51. Powers AM, Aguilar PV, Chandler LJ, Brault AC, Meakins TA, Watts D, et al. Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission. Am J Trop Med Hyg. 2006;75(3):461–9. 16968922
52. Azevedo RS, Silva EV, Carvalho VL, Rodrigues SG, Nunes-Neto JP, Monteiro H, et al. Mayaro fever virus, Brazilian Amazon. Emerg Infect Dis. 2009;15(11):1830–2. doi: 10.3201/eid1511.09046119891877
53. Terzian AC, Auguste AJ, Vedovello D, Ferreira MU, da Silva-Nunes M, Sperança MA, et al. Isolation and characterization of Mayaro virus from a human in Acre, Brazil. Am J Trop Med Hyg. 2015;92(2):401–4. doi: 10.4269/ajtmh.14-041725510721
54. Plante K, Wang E, Partidos CD, Weger J, Gorchakov R, Tsetsarkin K, et al. Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism. PLoS Pathog. 2011;7(7):e1002142. doi: 10.1371/journal.ppat.100214221829348